nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—SLC36A2—female reproductive system—breast cancer	0.0316	0.322	CbGeAlD
Cycloserine—Paresis—Toremifene—breast cancer	0.0278	0.0563	CcSEcCtD
Cycloserine—SLC36A2—endocrine gland—breast cancer	0.0267	0.272	CbGeAlD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.0221	0.0543	CbGpPWpGaD
Cycloserine—Paresis—Chlorambucil—breast cancer	0.0167	0.0338	CcSEcCtD
Cycloserine—DDC—Tryptophan metabolism—ALDH3A2—breast cancer	0.0155	0.0381	CbGpPWpGaD
Cycloserine—DDC—embryo—breast cancer	0.013	0.133	CbGeAlD
Cycloserine—Drug hypersensitivity—Goserelin—breast cancer	0.0129	0.0261	CcSEcCtD
Cycloserine—Paresis—Vinorelbine—breast cancer	0.0127	0.0258	CcSEcCtD
Cycloserine—Paresis—Thiotepa—breast cancer	0.0122	0.0246	CcSEcCtD
Cycloserine—SLC36A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.0114	0.028	CbGpPWpGaD
Cycloserine—DDC—Biogenic Amine Synthesis—ACHE—breast cancer	0.0109	0.0268	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.0108	0.0266	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—ALDH1A1—breast cancer	0.0106	0.0262	CbGpPWpGaD
Cycloserine—Neurological symptom—Paclitaxel—breast cancer	0.0104	0.0209	CcSEcCtD
Cycloserine—DDC—Dopamine metabolism—NQO1—breast cancer	0.0101	0.0249	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00988	0.0243	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00988	0.0243	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—GLI2—breast cancer	0.00949	0.0233	CbGpPWpGaD
Cycloserine—DDC—Amine-derived hormones—SLC5A5—breast cancer	0.0089	0.0219	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—COMT—breast cancer	0.00851	0.0209	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.00819	0.0201	CbGpPWpGaD
Cycloserine—DDC—female reproductive system—breast cancer	0.0079	0.0804	CbGeAlD
Cycloserine—Drug hypersensitivity—Paclitaxel—breast cancer	0.00776	0.0157	CcSEcCtD
Cycloserine—DDC—adrenal gland—breast cancer	0.00771	0.0784	CbGeAlD
Cycloserine—DDC—Biogenic Amine Synthesis—COMT—breast cancer	0.00759	0.0186	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—ALDH1A1—breast cancer	0.00756	0.0186	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.00749	0.0184	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.00721	0.0177	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.00721	0.0177	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—WNT1—breast cancer	0.00676	0.0166	CbGpPWpGaD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.0067	0.0165	CbGpPWpGaD
Cycloserine—DDC—endocrine gland—breast cancer	0.00669	0.068	CbGeAlD
Cycloserine—Osteoarthritis—Exemestane—breast cancer	0.00649	0.0131	CcSEcCtD
Cycloserine—Drug hypersensitivity—Capecitabine—breast cancer	0.00637	0.0129	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.00621	0.0153	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Idarubicin—breast cancer	0.00603	0.0122	CcSEcCtD
Cycloserine—Osteoarthritis—Anastrozole—breast cancer	0.00577	0.0117	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00549	0.0135	CbGpPWpGaD
Cycloserine—Paresis—Methotrexate—breast cancer	0.00524	0.0106	CcSEcCtD
Cycloserine—Paraesthesia—Fluoxymesterone—breast cancer	0.00505	0.0102	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.00502	0.0123	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.00502	0.0123	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP7—breast cancer	0.00483	0.0119	CbGpPWpGaD
Cycloserine—DDC—lymph node—breast cancer	0.00462	0.047	CbGeAlD
Cycloserine—Drug hypersensitivity—Epirubicin—breast cancer	0.00444	0.00897	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—DLX2—breast cancer	0.00442	0.0109	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PER3—breast cancer	0.00424	0.0104	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00416	0.0102	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—COX11—breast cancer	0.00416	0.0102	CbGpPWpGaD
Cycloserine—Tremor—Toremifene—breast cancer	0.00416	0.00841	CcSEcCtD
Cycloserine—Cardiac failure congestive—Goserelin—breast cancer	0.00416	0.0084	CcSEcCtD
Cycloserine—Hypersensitivity—Fluoxymesterone—breast cancer	0.00414	0.00837	CcSEcCtD
Cycloserine—Drug hypersensitivity—Doxorubicin—breast cancer	0.00411	0.0083	CcSEcCtD
Cycloserine—Dysarthria—Irinotecan—breast cancer	0.00405	0.00819	CcSEcCtD
Cycloserine—Vertigo—Fulvestrant—breast cancer	0.00404	0.00817	CcSEcCtD
Cycloserine—Vertigo—Toremifene—breast cancer	0.00399	0.00806	CcSEcCtD
Cycloserine—Osteoarthritis—Tamoxifen—breast cancer	0.00395	0.00797	CcSEcCtD
Cycloserine—Dysarthria—Fluorouracil—breast cancer	0.00388	0.00785	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.00381	0.00935	CbGpPWpGaD
Cycloserine—Osteoarthritis—Goserelin—breast cancer	0.00377	0.00762	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00373	0.00918	CbGpPWpGaD
Cycloserine—Psychotic disorder—Goserelin—breast cancer	0.00368	0.00744	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.00366	0.009	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.00366	0.009	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NR2F6—breast cancer	0.00361	0.00886	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—CYP3A4—breast cancer	0.0036	0.00885	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—CYP1B1—breast cancer	0.00354	0.0087	CbGpPWpGaD
Cycloserine—Headache—Fluoxymesterone—breast cancer	0.00352	0.00712	CcSEcCtD
Cycloserine—DDC—Parkinsons Disease Pathway—CCNE1—breast cancer	0.0034	0.00835	CbGpPWpGaD
Cycloserine—Coma—Fluorouracil—breast cancer	0.00336	0.00678	CcSEcCtD
Cycloserine—DDC—Tryptophan metabolism—CYP19A1—breast cancer	0.00333	0.00818	CbGpPWpGaD
Cycloserine—Paraesthesia—Fulvestrant—breast cancer	0.0033	0.00666	CcSEcCtD
Cycloserine—Confusional state—Exemestane—breast cancer	0.00322	0.0065	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.00315	0.00775	CbGpPWpGaD
Cycloserine—Vertigo—Letrozole—breast cancer	0.00312	0.00631	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—SHMT1—breast cancer	0.0031	0.00762	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Mitoxantrone—breast cancer	0.00307	0.0062	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.00299	0.00736	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Gemcitabine—breast cancer	0.00299	0.00604	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HADHB—breast cancer	0.00298	0.00733	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—YBX1—breast cancer	0.00298	0.00733	CbGpPWpGaD
Cycloserine—Disorientation—Fluorouracil—breast cancer	0.00298	0.00602	CcSEcCtD
Cycloserine—Vertigo—Raloxifene—breast cancer	0.00296	0.00598	CcSEcCtD
Cycloserine—Hypersensitivity—Lapatinib—breast cancer	0.00294	0.00595	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—CLDN4—breast cancer	0.00294	0.00723	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—ATF4—breast cancer	0.00294	0.00723	CbGpPWpGaD
Cycloserine—Drowsiness—Goserelin—breast cancer	0.0029	0.00587	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.00289	0.00711	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.00289	0.00709	CbGpPWpGaD
Cycloserine—Paraesthesia—Exemestane—breast cancer	0.00286	0.00579	CcSEcCtD
Cycloserine—Confusional state—Anastrozole—breast cancer	0.00286	0.00578	CcSEcCtD
Cycloserine—Convulsion—Idarubicin—breast cancer	0.00286	0.00577	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—THRB—breast cancer	0.00285	0.007	CbGpPWpGaD
Cycloserine—Osteoarthritis—Irinotecan—breast cancer	0.00278	0.00563	CcSEcCtD
Cycloserine—Dysarthria—Capecitabine—breast cancer	0.00271	0.00548	CcSEcCtD
Cycloserine—Hypersensitivity—Fulvestrant—breast cancer	0.00271	0.00547	CcSEcCtD
Cycloserine—Paraesthesia—Ixabepilone—breast cancer	0.0027	0.00546	CcSEcCtD
Cycloserine—DDC—Tryptophan metabolism—CYP1A1—breast cancer	0.00268	0.00659	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.00268	0.00659	CbGpPWpGaD
Cycloserine—Osteoarthritis—Fluorouracil—breast cancer	0.00267	0.00539	CcSEcCtD
Cycloserine—Feeling abnormal—Exemestane—breast cancer	0.00263	0.00531	CcSEcCtD
Cycloserine—Paraesthesia—Anastrozole—breast cancer	0.00254	0.00514	CcSEcCtD
Cycloserine—Paraesthesia—Letrozole—breast cancer	0.00254	0.00514	CcSEcCtD
Cycloserine—Somnolence—Letrozole—breast cancer	0.00252	0.00509	CcSEcCtD
Cycloserine—Somnolence—Anastrozole—breast cancer	0.00252	0.00509	CcSEcCtD
Cycloserine—Rash—Lapatinib—breast cancer	0.00252	0.00509	CcSEcCtD
Cycloserine—Dermatitis—Lapatinib—breast cancer	0.00251	0.00508	CcSEcCtD
Cycloserine—Cardiac failure congestive—Paclitaxel—breast cancer	0.0025	0.00506	CcSEcCtD
Cycloserine—Headache—Lapatinib—breast cancer	0.0025	0.00506	CcSEcCtD
Cycloserine—Tremor—Chlorambucil—breast cancer	0.0025	0.00505	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.00246	0.00604	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—ALDH7A1—breast cancer	0.00245	0.00603	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—PHGDH—breast cancer	0.00235	0.00578	CbGpPWpGaD
Cycloserine—Hypersensitivity—Exemestane—breast cancer	0.00235	0.00475	CcSEcCtD
Cycloserine—Feeling abnormal—Letrozole—breast cancer	0.00234	0.00472	CcSEcCtD
Cycloserine—Feeling abnormal—Anastrozole—breast cancer	0.00234	0.00472	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—NRIP1—breast cancer	0.00232	0.00571	CbGpPWpGaD
Cycloserine—Rash—Fulvestrant—breast cancer	0.00231	0.00468	CcSEcCtD
Cycloserine—Dermatitis—Fulvestrant—breast cancer	0.00231	0.00468	CcSEcCtD
Cycloserine—Convulsion—Chlorambucil—breast cancer	0.00231	0.00467	CcSEcCtD
Cycloserine—Headache—Fulvestrant—breast cancer	0.0023	0.00465	CcSEcCtD
Cycloserine—Rash—Toremifene—breast cancer	0.00228	0.00462	CcSEcCtD
Cycloserine—Dermatitis—Toremifene—breast cancer	0.00228	0.00461	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.00228	0.0056	CbGpPWpGaD
Cycloserine—Headache—Toremifene—breast cancer	0.00227	0.00459	CcSEcCtD
Cycloserine—Hypersensitivity—Ixabepilone—breast cancer	0.00222	0.00448	CcSEcCtD
Cycloserine—Vertigo—Vinblastine—breast cancer	0.0022	0.00444	CcSEcCtD
Cycloserine—Confusional state—Chlorambucil—breast cancer	0.0022	0.00444	CcSEcCtD
Cycloserine—Drowsiness—Mitoxantrone—breast cancer	0.00214	0.00434	CcSEcCtD
Cycloserine—Cardiac failure congestive—Docetaxel—breast cancer	0.00212	0.00429	CcSEcCtD
Cycloserine—Convulsion—Vinblastine—breast cancer	0.00212	0.00428	CcSEcCtD
Cycloserine—Hypersensitivity—Anastrozole—breast cancer	0.00209	0.00422	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.00207	0.00508	CbGpPWpGaD
Cycloserine—Dysarthria—Methotrexate—breast cancer	0.00202	0.00408	CcSEcCtD
Cycloserine—Convulsion—Melphalan—breast cancer	0.00202	0.00407	CcSEcCtD
Cycloserine—Rash—Exemestane—breast cancer	0.00201	0.00406	CcSEcCtD
Cycloserine—Dermatitis—Exemestane—breast cancer	0.00201	0.00406	CcSEcCtD
Cycloserine—Headache—Exemestane—breast cancer	0.002	0.00404	CcSEcCtD
Cycloserine—Hypersensitivity—Idarubicin—breast cancer	0.00198	0.00401	CcSEcCtD
Cycloserine—Convulsion—Goserelin—breast cancer	0.00197	0.00397	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.0019	0.00466	CbGpPWpGaD
Cycloserine—Rash—Ixabepilone—breast cancer	0.0019	0.00384	CcSEcCtD
Cycloserine—Dermatitis—Ixabepilone—breast cancer	0.0019	0.00383	CcSEcCtD
Cycloserine—Dysarthria—Epirubicin—breast cancer	0.00189	0.00382	CcSEcCtD
Cycloserine—Headache—Ixabepilone—breast cancer	0.00189	0.00381	CcSEcCtD
Cycloserine—Confusional state—Goserelin—breast cancer	0.00187	0.00377	CcSEcCtD
Cycloserine—Osteoarthritis—Capecitabine—breast cancer	0.00186	0.00377	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.00186	0.00458	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00186	0.00457	CbGpPWpGaD
Cycloserine—Vertigo—Vinorelbine—breast cancer	0.00183	0.00369	CcSEcCtD
Cycloserine—Feeling abnormal—Chlorambucil—breast cancer	0.00179	0.00363	CcSEcCtD
Cycloserine—Paraesthesia—Vinblastine—breast cancer	0.00179	0.00362	CcSEcCtD
Cycloserine—Rash—Letrozole—breast cancer	0.00179	0.00361	CcSEcCtD
Cycloserine—Rash—Anastrozole—breast cancer	0.00179	0.00361	CcSEcCtD
Cycloserine—Dermatitis—Anastrozole—breast cancer	0.00178	0.00361	CcSEcCtD
Cycloserine—Dermatitis—Letrozole—breast cancer	0.00178	0.00361	CcSEcCtD
Cycloserine—Headache—Letrozole—breast cancer	0.00178	0.00359	CcSEcCtD
Cycloserine—Headache—Anastrozole—breast cancer	0.00178	0.00359	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.00176	0.00432	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—STAT3—breast cancer	0.00175	0.00431	CbGpPWpGaD
Cycloserine—Dysarthria—Doxorubicin—breast cancer	0.00175	0.00354	CcSEcCtD
Cycloserine—Coma—Methotrexate—breast cancer	0.00175	0.00353	CcSEcCtD
Cycloserine—Paraesthesia—Tamoxifen—breast cancer	0.00174	0.00352	CcSEcCtD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP3—breast cancer	0.00173	0.00424	CbGpPWpGaD
Cycloserine—Paraesthesia—Melphalan—breast cancer	0.0017	0.00345	CcSEcCtD
Cycloserine—Rash—Raloxifene—breast cancer	0.0017	0.00343	CcSEcCtD
Cycloserine—Rash—Idarubicin—breast cancer	0.0017	0.00343	CcSEcCtD
Cycloserine—Dermatitis—Idarubicin—breast cancer	0.00169	0.00342	CcSEcCtD
Cycloserine—Dermatitis—Raloxifene—breast cancer	0.00169	0.00342	CcSEcCtD
Cycloserine—Headache—Idarubicin—breast cancer	0.00168	0.00341	CcSEcCtD
Cycloserine—Headache—Raloxifene—breast cancer	0.00168	0.00341	CcSEcCtD
Cycloserine—Convulsion—Thiotepa—breast cancer	0.00168	0.0034	CcSEcCtD
Cycloserine—Paraesthesia—Goserelin—breast cancer	0.00166	0.00336	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.00166	0.00407	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—MDM2—breast cancer	0.00166	0.00407	CbGpPWpGaD
Cycloserine—Somnolence—Goserelin—breast cancer	0.00165	0.00333	CcSEcCtD
Cycloserine—Feeling abnormal—Vinblastine—breast cancer	0.00164	0.00332	CcSEcCtD
Cycloserine—Coma—Epirubicin—breast cancer	0.00163	0.0033	CcSEcCtD
Cycloserine—DDC—Dopaminergic Neurogenesis—TGFB1—breast cancer	0.00162	0.00399	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—AHR—breast cancer	0.00161	0.00396	CbGpPWpGaD
Cycloserine—Hypersensitivity—Chlorambucil—breast cancer	0.0016	0.00324	CcSEcCtD
Cycloserine—Confusional state—Thiotepa—breast cancer	0.0016	0.00323	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.0016	0.00392	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—GATA3—breast cancer	0.00154	0.00378	CbGpPWpGaD
Cycloserine—Feeling abnormal—Goserelin—breast cancer	0.00153	0.00309	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.00152	0.00374	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—MTR—breast cancer	0.00151	0.00372	CbGpPWpGaD
Cycloserine—Coma—Doxorubicin—breast cancer	0.00151	0.00306	CcSEcCtD
Cycloserine—Vertigo—Irinotecan—breast cancer	0.00151	0.00304	CcSEcCtD
Cycloserine—Paraesthesia—Vinorelbine—breast cancer	0.00149	0.00301	CcSEcCtD
Cycloserine—Hypersensitivity—Vinblastine—breast cancer	0.00147	0.00297	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.00147	0.00361	CbGpPWpGaD
Cycloserine—Convulsion—Mitoxantrone—breast cancer	0.00145	0.00294	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—CPT1A—breast cancer	0.00144	0.00353	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Epirubicin—breast cancer	0.00143	0.00289	CcSEcCtD
Cycloserine—Hypersensitivity—Tamoxifen—breast cancer	0.00143	0.00289	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—ALB—breast cancer	0.00143	0.00351	CbGpPWpGaD
Cycloserine—Paraesthesia—Thiotepa—breast cancer	0.00142	0.00288	CcSEcCtD
Cycloserine—Somnolence—Thiotepa—breast cancer	0.00141	0.00285	CcSEcCtD
Cycloserine—Hypersensitivity—Melphalan—breast cancer	0.0014	0.00283	CcSEcCtD
Cycloserine—Convulsion—Fluorouracil—breast cancer	0.00139	0.00281	CcSEcCtD
Cycloserine—Osteoarthritis—Methotrexate—breast cancer	0.00139	0.0028	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—ESR2—breast cancer	0.00138	0.00339	CbGpPWpGaD
Cycloserine—Confusional state—Irinotecan—breast cancer	0.00138	0.00279	CcSEcCtD
Cycloserine—Confusional state—Mitoxantrone—breast cancer	0.00138	0.00279	CcSEcCtD
Cycloserine—Feeling abnormal—Vinorelbine—breast cancer	0.00137	0.00276	CcSEcCtD
Cycloserine—Hypersensitivity—Goserelin—breast cancer	0.00136	0.00276	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.00134	0.0033	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Doxorubicin—breast cancer	0.00132	0.00268	CcSEcCtD
Cycloserine—Confusional state—Fluorouracil—breast cancer	0.00132	0.00267	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—PLG—breast cancer	0.00131	0.00322	CbGpPWpGaD
Cycloserine—Feeling abnormal—Thiotepa—breast cancer	0.00131	0.00264	CcSEcCtD
Cycloserine—Osteoarthritis—Epirubicin—breast cancer	0.0013	0.00262	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—EGR1—breast cancer	0.00129	0.00317	CbGpPWpGaD
Cycloserine—Tremor—Paclitaxel—breast cancer	0.00128	0.00259	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—TOP2A—breast cancer	0.00128	0.00314	CbGpPWpGaD
Cycloserine—Headache—Vinblastine—breast cancer	0.00125	0.00253	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—SLC5A5—breast cancer	0.00124	0.00305	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NCOA2—breast cancer	0.00123	0.00303	CbGpPWpGaD
Cycloserine—Paraesthesia—Mitoxantrone—breast cancer	0.00123	0.00248	CcSEcCtD
Cycloserine—Paraesthesia—Irinotecan—breast cancer	0.00123	0.00248	CcSEcCtD
Cycloserine—Vertigo—Paclitaxel—breast cancer	0.00123	0.00248	CcSEcCtD
Cycloserine—Rash—Tamoxifen—breast cancer	0.00122	0.00247	CcSEcCtD
Cycloserine—Hypersensitivity—Vinorelbine—breast cancer	0.00122	0.00247	CcSEcCtD
Cycloserine—Dermatitis—Tamoxifen—breast cancer	0.00122	0.00247	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—AR—breast cancer	0.00122	0.003	CbGpPWpGaD
Cycloserine—Somnolence—Mitoxantrone—breast cancer	0.00122	0.00246	CcSEcCtD
Cycloserine—Somnolence—Irinotecan—breast cancer	0.00122	0.00246	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—EZH2—breast cancer	0.00122	0.00299	CbGpPWpGaD
Cycloserine—Headache—Tamoxifen—breast cancer	0.00121	0.00246	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.00121	0.00297	CbGpPWpGaD
Cycloserine—Osteoarthritis—Doxorubicin—breast cancer	0.0012	0.00243	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—NQO1—breast cancer	0.0012	0.00294	CbGpPWpGaD
Cycloserine—Rash—Melphalan—breast cancer	0.0012	0.00242	CcSEcCtD
Cycloserine—Paraesthesia—Gemcitabine—breast cancer	0.0012	0.00242	CcSEcCtD
Cycloserine—Dermatitis—Melphalan—breast cancer	0.0012	0.00242	CcSEcCtD
Cycloserine—Somnolence—Gemcitabine—breast cancer	0.00118	0.00239	CcSEcCtD
Cycloserine—Convulsion—Paclitaxel—breast cancer	0.00118	0.00239	CcSEcCtD
Cycloserine—Paraesthesia—Fluorouracil—breast cancer	0.00118	0.00238	CcSEcCtD
Cycloserine—Rash—Goserelin—breast cancer	0.00117	0.00236	CcSEcCtD
Cycloserine—Hypersensitivity—Thiotepa—breast cancer	0.00117	0.00236	CcSEcCtD
Cycloserine—Dermatitis—Goserelin—breast cancer	0.00117	0.00236	CcSEcCtD
Cycloserine—Somnolence—Fluorouracil—breast cancer	0.00116	0.00235	CcSEcCtD
Cycloserine—Headache—Goserelin—breast cancer	0.00116	0.00235	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCB1—breast cancer	0.00116	0.00285	CbGpPWpGaD
Cycloserine—Feeling abnormal—Mitoxantrone—breast cancer	0.00113	0.00228	CcSEcCtD
Cycloserine—Feeling abnormal—Irinotecan—breast cancer	0.00113	0.00228	CcSEcCtD
Cycloserine—Confusional state—Paclitaxel—breast cancer	0.00112	0.00227	CcSEcCtD
Cycloserine—Feeling abnormal—Gemcitabine—breast cancer	0.0011	0.00222	CcSEcCtD
Cycloserine—Feeling abnormal—Fluorouracil—breast cancer	0.00108	0.00218	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HES1—breast cancer	0.00107	0.00263	CbGpPWpGaD
Cycloserine—Drowsiness—Methotrexate—breast cancer	0.00107	0.00216	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—EGR1—breast cancer	0.00105	0.00259	CbGpPWpGaD
Cycloserine—Tremor—Capecitabine—breast cancer	0.00105	0.00212	CcSEcCtD
Cycloserine—Rash—Vinorelbine—breast cancer	0.00105	0.00211	CcSEcCtD
Cycloserine—Dermatitis—Vinorelbine—breast cancer	0.00104	0.00211	CcSEcCtD
Cycloserine—Headache—Vinorelbine—breast cancer	0.00104	0.0021	CcSEcCtD
Cycloserine—Vertigo—Capecitabine—breast cancer	0.00101	0.00204	CcSEcCtD
Cycloserine—Hypersensitivity—Irinotecan—breast cancer	0.00101	0.00204	CcSEcCtD
Cycloserine—Hypersensitivity—Mitoxantrone—breast cancer	0.00101	0.00204	CcSEcCtD
Cycloserine—Convulsion—Docetaxel—breast cancer	0.001	0.00203	CcSEcCtD
Cycloserine—Paraesthesia—Paclitaxel—breast cancer	0.001	0.00203	CcSEcCtD
Cycloserine—Drowsiness—Epirubicin—breast cancer	0.001	0.00202	CcSEcCtD
Cycloserine—Rash—Thiotepa—breast cancer	0.000999	0.00202	CcSEcCtD
Cycloserine—Dermatitis—Thiotepa—breast cancer	0.000998	0.00202	CcSEcCtD
Cycloserine—Headache—Thiotepa—breast cancer	0.000992	0.00201	CcSEcCtD
Cycloserine—Somnolence—Paclitaxel—breast cancer	0.000992	0.002	CcSEcCtD
Cycloserine—Hypersensitivity—Fluorouracil—breast cancer	0.000965	0.00195	CcSEcCtD
Cycloserine—Confusional state—Docetaxel—breast cancer	0.000954	0.00193	CcSEcCtD
Cycloserine—Drowsiness—Doxorubicin—breast cancer	0.000925	0.00187	CcSEcCtD
Cycloserine—Confusional state—Capecitabine—breast cancer	0.000923	0.00187	CcSEcCtD
Cycloserine—Feeling abnormal—Paclitaxel—breast cancer	0.000919	0.00186	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—SIRT1—breast cancer	0.000907	0.00223	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000898	0.00221	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—TYMS—breast cancer	0.00088	0.00216	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NCOR1—breast cancer	0.00087	0.00214	CbGpPWpGaD
Cycloserine—Rash—Irinotecan—breast cancer	0.000863	0.00174	CcSEcCtD
Cycloserine—Rash—Mitoxantrone—breast cancer	0.000863	0.00174	CcSEcCtD
Cycloserine—Dermatitis—Irinotecan—breast cancer	0.000862	0.00174	CcSEcCtD
Cycloserine—Dermatitis—Mitoxantrone—breast cancer	0.000862	0.00174	CcSEcCtD
Cycloserine—Headache—Irinotecan—breast cancer	0.000857	0.00173	CcSEcCtD
Cycloserine—Headache—Mitoxantrone—breast cancer	0.000857	0.00173	CcSEcCtD
Cycloserine—Paraesthesia—Docetaxel—breast cancer	0.000849	0.00172	CcSEcCtD
Cycloserine—Somnolence—Docetaxel—breast cancer	0.000841	0.0017	CcSEcCtD
Cycloserine—Rash—Gemcitabine—breast cancer	0.00084	0.0017	CcSEcCtD
Cycloserine—Dermatitis—Gemcitabine—breast cancer	0.000839	0.0017	CcSEcCtD
Cycloserine—Headache—Gemcitabine—breast cancer	0.000835	0.00169	CcSEcCtD
Cycloserine—Rash—Fluorouracil—breast cancer	0.000826	0.00167	CcSEcCtD
Cycloserine—Dermatitis—Fluorouracil—breast cancer	0.000825	0.00167	CcSEcCtD
Cycloserine—Paraesthesia—Capecitabine—breast cancer	0.000822	0.00166	CcSEcCtD
Cycloserine—Hypersensitivity—Paclitaxel—breast cancer	0.000822	0.00166	CcSEcCtD
Cycloserine—Headache—Fluorouracil—breast cancer	0.000821	0.00166	CcSEcCtD
Cycloserine—Feeling abnormal—Docetaxel—breast cancer	0.000779	0.00158	CcSEcCtD
Cycloserine—Feeling abnormal—Capecitabine—breast cancer	0.000755	0.00153	CcSEcCtD
Cycloserine—DDC—Metabolism—SYNJ2—breast cancer	0.000752	0.00185	CbGpPWpGaD
Cycloserine—Vertigo—Methotrexate—breast cancer	0.00075	0.00152	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ALB—breast cancer	0.000726	0.00178	CbGpPWpGaD
Cycloserine—Convulsion—Methotrexate—breast cancer	0.000724	0.00146	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—LEP—breast cancer	0.000716	0.00176	CbGpPWpGaD
Cycloserine—Rash—Paclitaxel—breast cancer	0.000703	0.00142	CcSEcCtD
Cycloserine—Dermatitis—Paclitaxel—breast cancer	0.000703	0.00142	CcSEcCtD
Cycloserine—Vertigo—Epirubicin—breast cancer	0.000702	0.00142	CcSEcCtD
Cycloserine—Headache—Paclitaxel—breast cancer	0.000699	0.00141	CcSEcCtD
Cycloserine—DDC—Metabolism—NDUFS3—breast cancer	0.000699	0.00172	CbGpPWpGaD
Cycloserine—Hypersensitivity—Docetaxel—breast cancer	0.000697	0.00141	CcSEcCtD
Cycloserine—Confusional state—Methotrexate—breast cancer	0.000687	0.00139	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—CDK4—breast cancer	0.000686	0.00169	CbGpPWpGaD
Cycloserine—Convulsion—Epirubicin—breast cancer	0.000677	0.00137	CcSEcCtD
Cycloserine—Hypersensitivity—Capecitabine—breast cancer	0.000675	0.00136	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—NOS2—breast cancer	0.000667	0.00164	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CHST9—breast cancer	0.000657	0.00161	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—RAF1—breast cancer	0.000656	0.00161	CbGpPWpGaD
Cycloserine—Vertigo—Doxorubicin—breast cancer	0.00065	0.00131	CcSEcCtD
Cycloserine—Confusional state—Epirubicin—breast cancer	0.000643	0.0013	CcSEcCtD
Cycloserine—Convulsion—Doxorubicin—breast cancer	0.000627	0.00127	CcSEcCtD
Cycloserine—DDC—Metabolism—COX11—breast cancer	0.000623	0.00153	CbGpPWpGaD
Cycloserine—Paraesthesia—Methotrexate—breast cancer	0.000612	0.00124	CcSEcCtD
Cycloserine—Somnolence—Methotrexate—breast cancer	0.000606	0.00122	CcSEcCtD
Cycloserine—Rash—Docetaxel—breast cancer	0.000596	0.00121	CcSEcCtD
Cycloserine—Dermatitis—Docetaxel—breast cancer	0.000596	0.0012	CcSEcCtD
Cycloserine—Confusional state—Doxorubicin—breast cancer	0.000595	0.0012	CcSEcCtD
Cycloserine—Headache—Docetaxel—breast cancer	0.000592	0.0012	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—CXCL8—breast cancer	0.000583	0.00143	CbGpPWpGaD
Cycloserine—Rash—Capecitabine—breast cancer	0.000577	0.00117	CcSEcCtD
Cycloserine—Dermatitis—Capecitabine—breast cancer	0.000577	0.00117	CcSEcCtD
Cycloserine—Headache—Capecitabine—breast cancer	0.000574	0.00116	CcSEcCtD
Cycloserine—Paraesthesia—Epirubicin—breast cancer	0.000573	0.00116	CcSEcCtD
Cycloserine—DDC—Metabolism—CDA—breast cancer	0.00057	0.0014	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SHMT1—breast cancer	0.00057	0.0014	CbGpPWpGaD
Cycloserine—Somnolence—Epirubicin—breast cancer	0.000567	0.00115	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—SERPINE1—breast cancer	0.000562	0.00138	CbGpPWpGaD
Cycloserine—Feeling abnormal—Methotrexate—breast cancer	0.000562	0.00114	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1B—breast cancer	0.000559	0.00137	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CASP3—breast cancer	0.000558	0.00137	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC2A5—breast cancer	0.000548	0.00135	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLCO1B1—breast cancer	0.000548	0.00135	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—JUN—breast cancer	0.000542	0.00133	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CTNNB1—breast cancer	0.000538	0.00132	CbGpPWpGaD
Cycloserine—Paraesthesia—Doxorubicin—breast cancer	0.00053	0.00107	CcSEcCtD
Cycloserine—DDC—Metabolism—APRT—breast cancer	0.00053	0.0013	CbGpPWpGaD
Cycloserine—Feeling abnormal—Epirubicin—breast cancer	0.000526	0.00106	CcSEcCtD
Cycloserine—Somnolence—Doxorubicin—breast cancer	0.000525	0.00106	CcSEcCtD
Cycloserine—Hypersensitivity—Methotrexate—breast cancer	0.000502	0.00102	CcSEcCtD
Cycloserine—DDC—Metabolism—ESRRA—breast cancer	0.000498	0.00122	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ANGPTL4—breast cancer	0.000498	0.00122	CbGpPWpGaD
Cycloserine—Feeling abnormal—Doxorubicin—breast cancer	0.000486	0.000983	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—VEGFA—breast cancer	0.000473	0.00116	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HADHB—breast cancer	0.000472	0.00116	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPI—breast cancer	0.000472	0.00116	CbGpPWpGaD
Cycloserine—Hypersensitivity—Epirubicin—breast cancer	0.00047	0.00095	CcSEcCtD
Cycloserine—DDC—Metabolism—ALDH1A1—breast cancer	0.00045	0.00111	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALDH7A1—breast cancer	0.00045	0.00111	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—JUN—breast cancer	0.000442	0.00109	CbGpPWpGaD
Cycloserine—Hypersensitivity—Doxorubicin—breast cancer	0.000435	0.000879	CcSEcCtD
Cycloserine—DDC—Metabolism—PHGDH—breast cancer	0.000432	0.00106	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ADSL—breast cancer	0.000432	0.00106	CbGpPWpGaD
Cycloserine—DDC—Metabolism—UMPS—breast cancer	0.000432	0.00106	CbGpPWpGaD
Cycloserine—DDC—Metabolism—FHL2—breast cancer	0.000432	0.00106	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NME1—breast cancer	0.000432	0.00106	CbGpPWpGaD
Cycloserine—Rash—Methotrexate—breast cancer	0.00043	0.000869	CcSEcCtD
Cycloserine—Dermatitis—Methotrexate—breast cancer	0.000429	0.000868	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—PTEN—breast cancer	0.000428	0.00105	CbGpPWpGaD
Cycloserine—Headache—Methotrexate—breast cancer	0.000427	0.000863	CcSEcCtD
Cycloserine—DDC—Metabolism—HPSE—breast cancer	0.000423	0.00104	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LDHB—breast cancer	0.000423	0.00104	CbGpPWpGaD
Cycloserine—DDC—Metabolism—BRIP1—breast cancer	0.000423	0.00104	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—MAPK8—breast cancer	0.000418	0.00103	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TNF—breast cancer	0.000406	0.000997	CbGpPWpGaD
Cycloserine—Rash—Epirubicin—breast cancer	0.000402	0.000813	CcSEcCtD
Cycloserine—Dermatitis—Epirubicin—breast cancer	0.000402	0.000812	CcSEcCtD
Cycloserine—DDC—Metabolism—GSTA3—breast cancer	0.000401	0.000986	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HMMR—breast cancer	0.000401	0.000986	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCC1—breast cancer	0.000401	0.000986	CbGpPWpGaD
Cycloserine—Headache—Epirubicin—breast cancer	0.0004	0.000808	CcSEcCtD
Cycloserine—DDC—Metabolism—PPARGC1B—breast cancer	0.000389	0.000955	CbGpPWpGaD
Cycloserine—Rash—Doxorubicin—breast cancer	0.000372	0.000752	CcSEcCtD
Cycloserine—Dermatitis—Doxorubicin—breast cancer	0.000372	0.000752	CcSEcCtD
Cycloserine—Headache—Doxorubicin—breast cancer	0.00037	0.000747	CcSEcCtD
Cycloserine—DDC—Metabolism—GSTA4—breast cancer	0.000367	0.000902	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CA9—breast cancer	0.000367	0.000902	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPX2—breast cancer	0.000358	0.000879	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTA2—breast cancer	0.000358	0.000879	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SULT1A1—breast cancer	0.000353	0.000868	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPX4—breast cancer	0.000353	0.000868	CbGpPWpGaD
Cycloserine—DDC—Metabolism—IDH1—breast cancer	0.000345	0.000848	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTA1—breast cancer	0.000345	0.000848	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NAT2—breast cancer	0.000341	0.000838	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL6—breast cancer	0.000327	0.000804	CbGpPWpGaD
Cycloserine—DDC—Metabolism—DPYD—breast cancer	0.000299	0.000735	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MED12—breast cancer	0.000299	0.000735	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALDOA—breast cancer	0.000295	0.000724	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—TP53—breast cancer	0.000292	0.000717	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NCOA3—breast cancer	0.000286	0.000703	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC2A2—breast cancer	0.000284	0.000698	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CPT1A—breast cancer	0.000278	0.000684	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MTR—breast cancer	0.000278	0.000684	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCG2—breast cancer	0.000278	0.000684	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HPGDS—breast cancer	0.000273	0.00067	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HBA1—breast cancer	0.000271	0.000666	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—IL6—breast cancer	0.000267	0.000657	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTT1—breast cancer	0.000265	0.00065	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ACHE—breast cancer	0.000265	0.00065	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP17A1—breast cancer	0.00025	0.000615	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTGS1—breast cancer	0.000248	0.000609	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ENO1—breast cancer	0.000248	0.000609	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP2D6—breast cancer	0.000243	0.000597	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NCOA2—breast cancer	0.000239	0.000586	CbGpPWpGaD
Cycloserine—DDC—Metabolism—FASN—breast cancer	0.000231	0.000569	CbGpPWpGaD
Cycloserine—DDC—Metabolism—BCHE—breast cancer	0.000231	0.000566	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC5A5—breast cancer	0.000228	0.000559	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NQO1—breast cancer	0.00022	0.00054	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC2A1—breast cancer	0.00022	0.00054	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP3A4—breast cancer	0.000214	0.000527	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP1B1—breast cancer	0.000211	0.000518	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HSP90AA1—breast cancer	0.000207	0.000508	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NCOA1—breast cancer	0.000201	0.000494	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP19A1—breast cancer	0.000198	0.000487	CbGpPWpGaD
Cycloserine—DDC—Metabolism—STK11—breast cancer	0.000198	0.000487	CbGpPWpGaD
Cycloserine—DDC—Metabolism—COMT—breast cancer	0.000184	0.000453	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTP1—breast cancer	0.000183	0.000451	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HMOX1—breast cancer	0.000181	0.000444	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ITPR1—breast cancer	0.00018	0.000443	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCB1—breast cancer	0.000174	0.000427	CbGpPWpGaD
Cycloserine—DDC—Metabolism—TYMS—breast cancer	0.000171	0.000419	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NCOR1—breast cancer	0.000169	0.000414	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLA2G4A—breast cancer	0.000169	0.000414	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTM1—breast cancer	0.000169	0.000414	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPX1—breast cancer	0.000161	0.000397	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP1A1—breast cancer	0.00016	0.000393	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ERCC2—breast cancer	0.000158	0.000389	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MTHFR—breast cancer	0.000149	0.000366	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CAV1—breast cancer	0.000137	0.000338	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CG—breast cancer	0.000125	0.000308	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CD—breast cancer	0.00011	0.00027	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALB—breast cancer	0.000109	0.000267	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NOS3—breast cancer	0.000104	0.000255	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CB—breast cancer	9.59e-05	0.000236	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTGS2—breast cancer	9.5e-05	0.000233	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTEN—breast cancer	8.29e-05	0.000204	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CA—breast cancer	5.85e-05	0.000144	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AKT1—breast cancer	4.78e-05	0.000117	CbGpPWpGaD
